ACE and chronic kidney disease: The Effect of Strict Blood Pressure Control and ACE Inhibition on the Progression of Chronic Kidney Disease in Pediatric Patients (ESCAPE) trial showed that lowering ambulatory blood pressure targets slows kidney disease progression and remains the basis for current clinical recommendations.1, 2, 3 Guidelines for blood pressure targets differ somewhat between European and US societies and mainly reference the use of ambulatory blood pressure monitoring.